MONOVISC for Hip Joint Pain Relief

2019 ◽  
Author(s):  
Keyword(s):  
Pain Relief ◽  
Hip Joint ◽  
Joint Pain

scholarly journals Percutaneous Radiofrequency Hip Joint Denervation

2021 ◽  
Author(s):  
Nieves Saiz-Sapena ◽  
Vicente Vanaclocha-Vanaclocha ◽  
José María Ortiz-Criado ◽  
Leyre Vanaclocha
Keyword(s):  
Quality Of Life ◽  
Pain Relief ◽  
Hip Joint ◽  
Pain Control ◽  
Joint Pain ◽  
Pulsed Radiofrequency ◽  
Total Hip ◽  
Sensory Denervation ◽  
Hip Arthroplasties

With an aging population, chronic osteoarthritic hip joint pain is becoming a major issue. Most patients with hip pain can control their pain with conservative measures but with a gradual reduction in their quality of life. When gradually reduced ambulation and pain become recalcitrant, total hip arthroplasty is the next step. For most patients, this is a good way to improve pain control and to recover some quality of life, but for a few this aggressive surgical procedure is not possible. Sometimes co-morbidities make total hip arthroplasties undesirable. At other times, the age of the patients recommends to wait for a while. In these cases, other options have to be explored. Percutaneous partial hip joint sensory denervation has become a notable option as it can provide acceptable rates of pain relief with minimal surgical aggressiveness. There are three modalities to perform it: thermal, cooled and pulsed radiofrequency.

scholarly journals No Association Between Intrauterine Contraceptive Devices and Musculoskeletal Hip Joint Pain

2021 ◽  
Author(s):  
Nathan H. Varady ◽  
Paul Abraham ◽  
Michael P. Kucharik ◽  
Christopher T. Eberlin ◽  
David Freccero ◽  
...  
Keyword(s):  
Hip Joint ◽  
Joint Pain ◽  
Contraceptive Devices ◽  
Intrauterine Contraceptive ◽  
Intrauterine Contraceptive Devices

scholarly journals Pulsed Radiofrequency Application on Femoral and Obturator Nerves for Hip Joint Pain: Retrospective Analysis with 12-Month Follow-up Results

2018 ◽  
Vol 1 (21;1) ◽  
pp. 407-414 ◽  
Author(s):  
Andrea Tinnirello
Keyword(s):  
Retrospective Analysis ◽  
Hip Joint ◽  
Joint Pain ◽  
Pulsed Radiofrequency ◽  
Single Center ◽  
Medium Term ◽  
Post Procedure ◽  
Single Center Study ◽  
Center Study

Background: Osteoarthritis of the hip joint is a common cause of pain and disability. Patients not responding to conservative management often cannot undergo joint replacement due to the presence of multiple comorbidities, while some other patients prefer to postpone surgery as long as possible. Radiofrequency denervation of articular branches of the femoral and obturator nerves, which supply innervation of the joint, is a novel technique to reduce hip joint pain. Previous studies reported positive results after application of continuous radiofrequency to the target nerves; however, this approach carries the potential risk of neuritis and neuroma formation. Pulsed radiofrequency (PRF) is a safer alternative to continuous radiofrequency not creating necrosis but a complex neuromodulatory effect on target nerves. There is no published evidence of PRF efficacy after 3 month follow-up. Objectives: This single-center study objective was to evaluate the short and medium term effectiveness of PRF on the femoral articular branches and obturator nerves in patients with chronic hip pain. Study Design: Retrospective single-center study. Setting: Italian National Health Service Public Hospital. Methods: Retrospective analysis of 14 patients treated with PRF for severe hip joint pain (mean numeric rating scale (NRS) 7.7 ± 1.2 mean Oxford Hip Score (OHS) 20 ± 8.4). Mean pain and disability scores were evaluated with NRS and OHS respectively at 1, 3, 6, and 12-month follow-up. All patients were treated with pulsed radiofrequency applied under fluoroscopy on the articular branches of the femoral and obturator nerves for 300 seconds each. Results: Eight patients out of 14 (57%) reported an NRS reduction > 50% at 1 month post procedure. Overall, both pain and disability scores were significantly (P < 0.01) lower at all follow-up until 6 months, mean NRS at 1, 3, and 6 months was 3.6 ± 3; 4.1 ± 3.3; 4.8 ± 2.9 while OHS was 37.6 ± 17.7; 35.8 ± 17.7; 35.8 ± 14 respectively. At 12 months, NRS was 5.8 ± 2.4 while OHS 23.3 ± 12.7, it must be pointed out that even if both scores are significantly (P < 0.01) lower than basal, only 3 patients out of 14 (21%) maintained a NRS reduction > 50% from basal at 12 months post procedure. We reported 2 femoral artery punctures without any significant complication. Limitations: Retrospective study, small sample size. Conclusions: Pulsed radiofrequency is a safe and effective modality to treat hip joint pain in the short and medium term. Definition of positive outcome predictors is required to reserve radiofrequency treatment only for those patients who can benefit from this procedure. Key words: Hip joint pain, pulsed radiofrequency, obturator nerve, femoral nerve, interventional pain management, radiofrequency

scholarly journals Coxitis in early axial spondyloarthritis

2019 ◽  
Vol 13 (4) ◽  
pp. 41-47 ◽  
Author(s):  
E. M. Agafonova ◽  
T. V. Dubinina ◽  
D. G. Rumyantseva ◽  
A. B. Demina ◽  
A. V. Smirnov ◽  
...  
Keyword(s):  
Disease Activity ◽  
Hip Joint ◽  
Joint Pain ◽  
Rating Scale ◽  
Axial Spondyloarthritis ◽  
Clinical Signs ◽  
Clinical Manifestations ◽  
Diagnostic Methods ◽  
Joint Movement ◽  
Joint Injury

In Russia, coxitis is one of the most common extra-axial manifestations of ankylosing spondylitis (AS). However, many issues regarding its early diagnosis remain unresolved.Objective: to compare the clinical manifestations of coxitis with the data from an instrumental examination of CoRSAR cohort (Cohort of Early Axial Spondyloarthritis) patients.Patients and methods. Examinations were made in 175 patients (mean age, 28.2±5.7 years) diagnosed as having axial spondyloarthritis (axSpA) with inflammatory back pain lasting up to 5 years, which occurred at the age of ≤45 years. There was non-radiographic axSpA (nraxSpA) in 69 patients and AS in 106 patients. 87% of patients were HLA-B27-positive. The median disease duration was 23.8 [1–60] months; BASDAI was 3.3±1.94. Regardless of complaints, all the patients underwent hip X-ray and ultrasound studies and 54 more patients had magnetic resonance imaging (MRI).Results and discussion. The clinical signs of coxitis were present in 95 (54%) patients, of them 60% were diagnosed with AS and 40% had nraxSpA. According to the numerical pain rating scale (NPRS), the median hip joint pain was 4 [3; 7]. Limited joint movement was observed in 6 (3.4%) patients. The level of hip joint pain correlated with BASDAI (r=0.53) and ASDAS (r=0.30). The ultrasound signs of coxitis were detected in 42 (24%) patients; of them 26 (62%) had the clinical manifestations of hip joint injury, and such changes were absent in 16 patients. The patients with ultrasound signs of coxitis were noted to have a higher disease activity; peripheral arthritis and enthesitis were more common. According to MRI, coxitis was diagnosed in 39 (72%) of the 54 examinees, while the disease was asymptomatic in 10%.Conclusion. Different diagnostic methods used in patients with early axSpA could reveal coxitis in 33% of cases. The patients with coxitis show higher laboratory disease activity than those without hip joint injury. It is necessary to include MRI and ultrasound in the mandatory examination of patients with axSpA.

scholarly journals The Use of Botulinum Toxin for the Treatment of Chronic Joint Pain: Clinical and Experimental Evidence

Toxins ◽  
2020 ◽  
Vol 12 (5) ◽  
pp. 314 ◽  
Author(s):  
Nicole Blanshan ◽  
Hollis Krug
Keyword(s):  
Pain Relief ◽  
Joint Pain ◽  
Peripheral Sensitization ◽  
Long Term Effects ◽  
Neuropeptide Release ◽  
Osteoarthritis Pain ◽  
Catalytically Active ◽  
The Central Nervous System ◽  
The Brain

Chronic osteoarthritis pain is an increasing worldwide problem. Treatment for osteoarthritis pain is generally inadequate or fraught with potential toxicities. Botulinum toxins (BoNTs) are potent inhibitors of neuropeptide release. Paralytic toxicity is due to inhibition at the neuromuscular junction, and this effect has been utilized for treatments of painful dystonias. Pain relief following BoNT muscle injection has been noted to be more significant than muscle weakness and hypothesized to occur because of the inhibition of peripheral neuropeptide release and reduction of peripheral sensitization. Because of this observation, BoNT has been studied as an intra-articular (IA) analgesic for chronic joint pain. In clinical trials, BoNT appears to be effective for nociceptive joint pain. No toxicity has been reported. In preclinical models of joint pain, BoNT is similarly effective. Examination of the dorsal root ganglion (DRG) and the central nervous system has shown that catalytically active BoNT is retrogradely transported by neurons and then transcytosed to afferent synapses in the brain. This suggests that pain relief may also be due to the central effects of the drug. In summary, BoNT appears to be safe and effective for the treatment of chronic joint pain. The long-term effects of IA BoNT are still being determined.

Radiofrequency ablation of the sacroiliac joint

2021 ◽  
pp. 83-92
Author(s):  
Haider M. Ali ◽  
Yashar Eshraghi ◽  
Maged Guirguis
Keyword(s):  
Radiofrequency Ablation ◽  
Pain Management ◽  
Pain Relief ◽  
Sacroiliac Joint ◽  
Joint Pain ◽  
Positive Response ◽  
Lateral Branch ◽  
Tissue Destruction ◽  
Sacroiliac Joint Pain ◽  
Pain Syndromes

Radiofrequency ablation (RFA) is a revolutionary procedure in the practice of pain management that can be used in the treatment of sacroiliac joint pain syndromes. It is a technology that uses radiofrequency needle probes to create lesions by way of localized tissue destruction. It is indicated for patients with chronic sacroiliac joint pain who have had a positive response to a lateral branch block. This procedure typically provides at least 6 and up to 12 months of significant pain relief and can be repeated. Practitioners should be well versed in the different evolving methods for RFA as well as its evidence, relevant anatomy, the technology used in RFA, and the complications that may occur with this procedure and how to prevent them. This chapter explores these principles and presents the relevant findings from the literature for this innovative procedure for sacroiliac joint pain.

Hip Joint Pain

Pain ◽  
2019 ◽  
pp. 757-760
Author(s):  
Peter A. Gold ◽  
Mark R. Jones ◽  
Alan David Kaye
Keyword(s):  
Hip Joint ◽  
Joint Pain

scholarly journals Persons With Chronic Hip Joint Pain Exhibit Reduced Hip Muscle Strength

2014 ◽  
Vol 44 (11) ◽  
pp. 890-898 ◽  
Author(s):  
Marcie Harris-Hayes ◽  
Michael J. Mueller ◽  
Shirley A. Sahrmann ◽  
Nancy J. Bloom ◽  
Karen Steger-May ◽  
...  
Keyword(s):  
Muscle Strength ◽  
Hip Joint ◽  
Joint Pain ◽  
Hip Muscle

scholarly journals Relationship between Physical Activity Level and Hip Joint Pain in Adult Women with Chiari Pelvic Osteotomy

2012 ◽  
Vol 24 (7) ◽  
pp. 561-565
Author(s):  
Yoshiharu Nagai ◽  
Tetsuo Maeda ◽  
Ryoji Kiyama ◽  
Akihiko Oowatashi ◽  
Hideo Kaneko ◽  
...  
Keyword(s):  
Physical Activity ◽  
Hip Joint ◽  
Physical Activity Level ◽  
Joint Pain ◽  
Pelvic Osteotomy ◽  
Activity Level ◽  
Adult Women ◽  
Chiari Pelvic Osteotomy
Sign in / Sign up

Export Citation Format

Share Document